Welcome to the Hatter Cardiovascular Institute
The Hatter Cardiovascular Institute (HCI) was established as a Clinical & Basic Cardiovascular Research facility at University College London in 1990 with an aim of gaining a greater understanding of cardiovascular disease and to generate new therapeutic strategies for the treatment of ischaemic heart disease. Since that time, the HCI has developed into one of the world’s leading centres for the study of cardiovascular disease and is credited with pioneering discoveries on how to protect the heart from damage during a heart attack.
Based on our expertise gained in cardiovascular disease, we have developed additional research programmes focusing on (1) neuroprotection specific to ischaemic stroke, (2) the cardio-renal syndrome, addressing the impact on the heart from chronic kidney disease and (3) cardio-oncology, investigating how best to reduce the damage to the heart following chemotherapy.
Within our framework, as part of UCL’s overall Institute of Cardiovascular Science, we undertake basic and clinical research at the highest level, train clinical and basic scientists, organise annual national and international conferences, all with the underlying aim to improve the treatment options available to patients.
